Jefferson University Hospitals

Physician Profile

Thomas Klumpp, MD

Jefferson University Physician

Academic Title: Professor

Specialties
Medical Oncology - Hematologic Malignancies (Not Accepting New Patients)
Medical Oncology - Leukemia/Lymphoma (Not Accepting New Patients)
Medical Oncology (Not Accepting New Patients)

Office Locations

Philadelphia
925 Chestnut Street
Suite 320A
Philadelphia PA 19107
Phone: (215) 955-8874
Fax: (215) 503-7697

Medical Services

Board Certifications

  • Medical Oncology
  • Hematology
  • Internal Medicine

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital

Education

  • University of Pennsylvania School of Medicine, Medical School

Internship

  • Dartmouth Medical Center

Residency

  • Dartmouth Medical Center

Fellowship

  • Massachusetts General Hospital, Boston, MA
  • Dana Farber Cancer Institute

Recent Publications

Donor Lymphocyte Infusion in Hematologic Malignancies - Good to be Fresh?

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies

Impact of chronic graft-versus-host disease on late relapse and survival on 7,489 patients after myeloablative allogeneic hematopoietic cell transplantation for leukemia

Center for international blood and marrow transplant research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort

Increasing Incidence of Chronic Graft-versus-Host Disease inAllogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation

Electronic medical records and quality of cancer care

Providing personalized prognostic information for adult leukemia survivors

Outcome of Lower-Intensity Allogeneic Transplantation in Non-Hodgkin Lymphoma after Autologous Transplantation Failure

HLA DR15 Antigen Status Does Not Impact Graft-versus-Host Disease or Survival in HLA-Matched Sibling Transplantation for Hematologic Malignancies

Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant

Classifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center forInternational Blood and Marrow Transplant Research Study

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease

Chronic GVHD risk score: A Center for International Blood and Marrow Transplant Research analysis

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission

A Comparison of HLA-Identical Sibling Allogeneic versus Autologous Transplantation for Diffuse Large B Cell Lymphoma: A Report from the CIBMTR

Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies

A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation

Unrelated donor transplants in adults with philadelphia-negative acute lymphoblastic leukemia in first complete remission